Has the development of PET come to an end with PET-CT?;Ist die entwicklung des PET mit dem PET/CT beendet?

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 177, Issue 1, 2005, Pages 14-16

  Bockisch, Andreas ^a   Rosenbaum, S ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; CHOLINE; FLUORINE 18; FLUORODEOXYGLUCOSE; GALLIUM 68; IODINE 124; METIROSINE; OXYGEN 15; RADIOPHARMACEUTICAL AGENT;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EDITORIAL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MYOCARDIAL DISEASE; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BRAIN DISEASES; COMPUTERS; HEART DISEASES; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SOFTWARE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 12344327789     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813881     Document Type: Editorial

References (15)

1. Löffler M, Weckesser M, Franzius C et al. Malignant melanoma and (18)F-FDG-PET: Should the whole body scan include the legs? Nuklearmedizin 2003; 42: 167-172
2. Menzel C, Dobert N, Rieker O et al. 18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading. Nuklearmedizin 2003; 42: 90-93
3. Weber WA, Dietlein M, Hellwig D et al. PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer. Nuklearmedizin 2003; 42: 135-144
4. Rosa F, Meimarakis G, Stahl A et al. Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease. Nuklearmedizin 2004; 43: 135-140
5. Dietlein M, Weber W, Schwaiger M et al. 18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer. Nuklearmedizin 2003; 42: 145-156
6. Bartenstein P. PET in neuroscience: dopaminergic, GABA/benzodiazepine, and opiate system. Nuklearmedizin 2004; 43: 33-42
7. Brink I, Nitzsche EU, Mix M et al. Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading. Nuklearmedizin 2003; 42: 39-44
8. Aigner RM, Schultes G, Wolf G et al. 18F-FDG PET: early postoperative period of oro-maxillo-facial flaps. Nuklearmedizin 2003; 42: 210-214
9. Cremerius U, Mumme T, Reinartz P et al. Analysis of (18)F-FDG uptake patterns in PET for diagnosis of septic and aseptic loosening after total hip arthroplasty. Nuklearmedizin 2003; 42: 234-239
10. Gambhir S, Czernin J, Schwimmer J et al. A Tabulated Summary of the FDG PET Literature. J Nucl Med 2001; 42: 1S-93S
11. Antoch G, Forsting M. Wieviel CT braucht die PET/CT? Nuklearmedizin 2004; 43: 141-142
12. Kotzerke J, Volkmer BG, Glatting G et al. Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin 2003; 42: 25-30
13. Plotkin M, Amthauer H, Merschhemke M et al. Use of statistical parametric mapping of (18) F-FDG-PET in frontal lobe epilepsy. Nuklearmedizin 2003; 42: 190-196
14. Hautzel H, Mottaghy FM, Schmidt D et al. Neurocognition and PET. Strategies for data analysis in activation studies on working memory. Nuklearmedizin 2003; 42: 197-209
15. Doll J, Henze M, Bublitz O et al. High resolution reconstruction of PET images using the iterative OSEM algorithm. Nuklearmedizin 2004; 43: 72-78